middle.news

Bod Science Posts $51k Cash Inflow Amid Ongoing DOCA and Biortica Deal

3:49pm on Friday 24th of January, 2025 AEDT Pharmaceuticals
Read Story

Bod Science Posts $51k Cash Inflow Amid Ongoing DOCA and Biortica Deal

3:49pm on Friday 24th of January, 2025 AEDT
Key Points
  • Net cash inflow from operating activities of $51k in Q2 FY2025
  • Customer receipts rose 14% quarter-on-quarter to $219k
  • Sale of intellectual property assets generated $125k proceeds
  • Company remains suspended under DOCA with administration ongoing
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about BOD
OPEN ARTICLE